ACET

2.17011.79%
LK

Lloyd Klickstein

Interim Chief Medical Officer & Director

Dr. Lloyd Klickstein, M.D., Ph.D. is Member of Scientific Advisory Board at Carbon Biosciences, Inc. from May 2024. He served as Member of Scientific Advisory Board at Adicet Bio, Inc since February 19, 2021 until August 2024 and is its Director since August 2024 and served as Chief Innovation Officer since September 2020 until February 19, 2021 and also serves as its Interim Chief Medical Officer since August 2026. He is Member of Scientific Advisory Board of HBM Holdings Limited from 2026. He currently serves as President and Chief Executive Officer of Koslapp Therapeutics, Inc. and is the Board Chair of the Lupus Foundation of New England. Dr. Klickstein co-founded Versanis Bio, Inc. He served as an independent board member at Blade Therapeutics, Inc. He served as Chief Executive Officer at Versanis Bio, Inc. until July 2022 and serves as its President & Chief Scientific Officer since July 2022. Dr. Klickstein served as Chief Scientific Officer of resTORbio, Inc. since May 2019. Prior to joining resTORbio, Dr. Klickstein was Head of Translational Medicine for the New Indication Discovery Unit (NIDU) and the Exploratory Disease Area (DAx) at Novartis Institutes for Biomedical Research. Under his decade of leadership, NIDU & DAx teams carried multiple projects forward from target identification through clinical proof-of-concept in novel areas of drug development including liver disease, hearing loss and aging, among others. Prior to his 13 years at Novartis, Dr. Klickstein was an academic physician-scientist at Brigham & Women’s Hospital (BWH) in Boston, where he directed an NIH-funded basic research laboratory and maintained an active clinical practice in the Arthritis Center. Dr. Klickstein received his B.S. degree from Tufts University, his M.D. and Ph.D. degrees from Harvard University, completed post-graduate clinical training in Internal Medicine, Rheumatology & Immunology at BWH and a post-doctoral research fellowship at the Center for Blood Research in Boston.

Positions